Atezolizumab for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Oct 2019: Trial registered, NCT04138628
  2. 24 Mar 2020: Trial started, NCT04138628

The trials

NCT04138628: Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy

State
Under way
Phase
Phase 2
People
154 taking part
Started
24 Mar 2020
Primary completion
1 Aug 2024
Arms
ctDNA screening arm
Results
None posted
  1. 24 Oct 2019: Trial registered
  2. 24 Mar 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.